MGNX

MKT CAP:$263M

MacroGenics Inc

Market Cap

$263M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$3.91+$2.30 (+142.86%)

Jun 5, 2026

52W High $4.5352W Low $1.19

Company Details

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The company's product pipeline includes lorig...

CEO

—

IPO Date

Oct 10, 2013

Website

www.macrogenics.com

Key Metrics TTM

Revenue

$157M

+3.1% YoY

Net Income

-$70M

EPS (Diluted)

Free Cash Flow

-$72M

Revenue / Share

$2.48

Gross Margin

69.9%

Operating Margin

-40.5%

Net Margin

-44.8%

FCF Margin

-45.6%

P/S

1.7x

P/E

Earnings Reports

Q1 2026

May 13, 2026

$21M+57.5%

FY 2025

Mar 9, 2026

$150M+0.8%

Q4 2025

Mar 9, 2026

$41M+132.5%

Q3 2025

Nov 12, 2025

$73M-34.2%

Q2 2025

Aug 14, 2025

$22M+106.0%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee